BrainStorm's NurOwn Data Selected as Breakthrough Science for Presentation at ISCT 2025 Meeting (PRNewswire) - Apr 29, 2025 - "BrainStorm Cell Therapeutics Inc...announced the acceptance of new pharmacogenomic data for oral presentation of new findings on NurOwn at the International Society for Cell & Gene Therapy (ISCT) 2025 Annual Meeting, to take place from May 6 - 10, 2025 in New Orleans. The data highlight the impact of the UNC13A genotype on clinical outcomes for amyotrophic lateral sclerosis (ALS) patients treated with NurOwn (debamestrocel)."
P3 data • Amyotrophic Lateral Sclerosis
|